Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 200 Results

Title
Intervention Indication Therapeutic Area Year Actions
STS101 for the acute treatment of migraine STS-101 (TO-2070, dihydroergotamine) Migraine Neurology 2022 View  |  Download
Spesolimab for preventing generalised pustular psoriasis flares Spesolimab (BI 655130) Generalised pustular psoriasis flares Dermatology 2022 View  |  Download
Sotatercept for treating pulmonary arterial hypertension Sotatercep (ACE-011) Pulmonary arterial hypertension (PAH) Cardiovascular System , Respiratory System 2022 View  |  Download
Sodium phenylbutyrate-ursodoxicoltaurine for treating amyotrophic lateral sclerosis Sodium phenylbutyrate-ursodoxicoltaurine Amyotrophic lateral sclerosis Neurology 2022 View  |  Download
Setmelanotide for treating obesity caused by rare genetic disorders in children aged 2 to 6 years Setmelanotide (RM-493) Obesity Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Semaglutide for treating peripheral arterial disease (PAD) and type 2 diabetes Semaglutide (Ozempic) Peripheral arterial disease (PAD) , Type 2 diabetes Cardiovascular System , Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Semaglutide for treating overweight and obesity in adolescents ages 12 to 17 years old Semaglutide (Ozempic) Obesity Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Semaglutide for treating overweight and obesity Semaglutide (Ozempic) Obesity Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Semaglutide for treating obesity-related heart failure Semaglutide (Ozempic) Obesity-related heart failure Cardiovascular System , Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Selpercatinib for previously untreated medullary thyroid cancer with RET mutation in patients ages 12 and older Selpercatinib (LOXO-292; LY3527723) Medullary thyroid cancer (MTC) Head and Neck Cancer 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications